(Q44247893)

English

Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics

scientific article published in April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics (English)

1 reference

Europe PubMed Central

1 December 2017

Acute decompensated heart failure

1 reference

based on heuristic

inferred from title

6

object named as

Barry E Bleske

1 reference

Europe PubMed Central

1 December 2017

Michael P Dorsch

2

object named as

Michael P Dorsch

1 reference

Europe PubMed Central

1 December 2017

author name string

Megan M Clarke

1

1 reference

Europe PubMed Central

1 December 2017

Susie Kim

3

1 reference

Europe PubMed Central

1 December 2017

Keith D Aaronson

4

1 reference

Europe PubMed Central

1 December 2017

Todd M Koelling

5

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

1 April 2013

1 reference

Europe PubMed Central

1 December 2017

Pharmacotherapy

1 reference

Europe PubMed Central

1 December 2017

33

1 reference

Europe PubMed Central

1 December 2017

6

1 reference

Europe PubMed Central

1 December 2017

583-588

1 reference

Europe PubMed Central

1 December 2017

Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH).

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

The prognostic importance of different definitions of worsening renal function in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Cardiorenal interactions: insights from the ESCAPE trial

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Human serum albumin in the clinical syndrome of heart failure

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Albumin: biochemical properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Serum albumin and mortality in acutely decompensated heart failure

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1241

21 January 2018

Identifiers

10.1002/PHAR.1241

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44247893&oldid=2108895488"